Anti-VEGF versus laser therapy for retinopathy of prematurity: a systematic review and meta-analysis focusing on recurrence patterns and retreatment needs

Key Points

• Anti-VEGF therapy shows significant reduction in recurrence patterns for treating retinopathy of prematurity.
• A total of 60 studies were analyzed to determine differences in retreatment needs between therapies.
• Systematic review and meta-analysis were used to evaluate clinical outcomes and patterns of recurrence.
• Findings highlight that anti-VEGF therapy may lead to lower retreatment rates, indicating a potential preference.